Latest ENZ reports update at 2024-03-13: 2023-Q42023-Q22022-Q4
Enzo Biochem logo

Enzo Biochem ENZ

$ 1.12 2.75%

Country

usaUSA

IPO year

-

Industry

Diagnostics research

Stock Exchange

NYSE

CEO

Dr. Elazar Rabbani

Employees in the company

408

Shares

49.2 K

Market Cap[1]

$ 55.1 K

EBITDA (LTM)

$ -16.7 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.